Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice
Jin, W.; Huang, W.; Chen, L.; Jin, M.; Wang, Q.; Gao, Z.; Jin, Z. Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice. Int. J. Mol. Sci. 2018, 19, 3973.
Jin W, Huang W, Chen L, Jin M, Wang Q, Gao Z, Jin Z. Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice. International Journal of Molecular Sciences. 2018; 19(12):3973.
Chicago/Turabian StyleJin, Wenyu; Huang, Wei; Chen, Liqing; Jin, Mingji; Wang, Qiming; Gao, Zhonggao; Jin, Zhehu. 2018. "Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice" Int. J. Mol. Sci. 19, no. 12: 3973.